NO983464D0 - Buffer systems for stabilizing pharmaceutical preparations - Google Patents
Buffer systems for stabilizing pharmaceutical preparationsInfo
- Publication number
- NO983464D0 NO983464D0 NO983464A NO983464A NO983464D0 NO 983464 D0 NO983464 D0 NO 983464D0 NO 983464 A NO983464 A NO 983464A NO 983464 A NO983464 A NO 983464A NO 983464 D0 NO983464 D0 NO 983464D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- buffer systems
- stabilizing pharmaceutical
- stabilizing
- buffer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19604230 | 1996-01-29 | ||
PCT/DE1996/002488 WO1997028104A2 (en) | 1996-01-29 | 1996-12-20 | Buffer systems for use in stabilizing pharmaceutical preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983464L NO983464L (en) | 1998-07-28 |
NO983464D0 true NO983464D0 (en) | 1998-07-28 |
Family
ID=7784639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983464A NO983464D0 (en) | 1996-01-29 | 1998-07-28 | Buffer systems for stabilizing pharmaceutical preparations |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0877628A2 (en) |
JP (1) | JP2000504334A (en) |
AU (1) | AU1870497A (en) |
CA (1) | CA2244213A1 (en) |
DE (1) | DE19648650C2 (en) |
NO (1) | NO983464D0 (en) |
WO (1) | WO1997028104A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250153B2 (en) * | 2002-12-12 | 2007-07-31 | Biophysica Research, Inc. | Contrast media formulations having improved biological tolerance |
JP2005170928A (en) * | 2003-10-21 | 2005-06-30 | Konica Minolta Medical & Graphic Inc | Lyposome-containing x ray-imaging agent and method for producing the same |
JP2005170923A (en) * | 2003-10-21 | 2005-06-30 | Konica Minolta Medical & Graphic Inc | Lyposome-containing x ray-imaging agent and method for producing the same |
JP2005220034A (en) * | 2004-02-03 | 2005-08-18 | Konica Minolta Medical & Graphic Inc | Method for producing contrast medium for roentgenologic examination |
JP4654590B2 (en) * | 2004-03-31 | 2011-03-23 | コニカミノルタエムジー株式会社 | Contrast composition for X-ray CT and method for producing the same |
WO2006009022A1 (en) * | 2004-07-21 | 2006-01-26 | Konica Minolta Medical & Graphic, Inc. | Liposome-containing x-ray radiopaque dye and process for producing the same |
JP5947784B2 (en) * | 2010-03-23 | 2016-07-06 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | Method for producing stabilized X-ray diagnostic composition |
EP2883542B1 (en) | 2012-08-10 | 2019-05-01 | Taiho Pharmaceutical Co., Ltd. | Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same |
US9987314B2 (en) | 2013-10-25 | 2018-06-05 | Psioxus Therapeutics Limited | Oncolytic adenoviruses armed with heterologous genes |
JP6867639B2 (en) * | 2016-10-11 | 2021-05-12 | 学校法人 聖マリアンナ医科大学 | Combined nonionic iodine contrast agent |
GB201801614D0 (en) * | 2018-01-31 | 2018-03-14 | Psioxus Therapeutics Ltd | Formulation |
EP4011369A1 (en) | 2020-12-14 | 2022-06-15 | G.L. Pharma GmbH | Aqueous pharmaceutical composition comprising tapentadol tartrate |
JP7353453B1 (en) | 2022-10-31 | 2023-09-29 | キユーピー株式会社 | Emulsion and its manufacturing method |
JP7372429B1 (en) | 2022-10-31 | 2023-10-31 | キユーピー株式会社 | Emulsion and its manufacturing method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR222337A1 (en) * | 1978-07-04 | 1981-05-15 | Nyegaard & Co As | PROCEDURE FOR PREPARING A PHYSIOLOGICALLY ACCEPTABLE INJECTABLE STERILE SOLUTION FROM AN X-RAY CONTRAST AGENT |
GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
DE4121568C2 (en) * | 1991-04-22 | 1997-07-03 | Schering Ag | Method and device for producing a contrast medium from a concentrate |
IT1256248B (en) * | 1992-12-24 | 1995-11-29 | Bracco Spa | WATER INJECTABLE FORMULATIONS FOR RADIODIAGNOSTICS INCLUDING MIXTURES OF IODURATED AROMATIC COMPOUNDS USEFUL AS X-RAY MATTING AGENTS |
-
1996
- 1996-11-15 DE DE19648650A patent/DE19648650C2/en not_active Expired - Fee Related
- 1996-12-20 AU AU18704/97A patent/AU1870497A/en not_active Abandoned
- 1996-12-20 EP EP96946112A patent/EP0877628A2/en not_active Withdrawn
- 1996-12-20 CA CA002244213A patent/CA2244213A1/en not_active Abandoned
- 1996-12-20 WO PCT/DE1996/002488 patent/WO1997028104A2/en not_active Application Discontinuation
- 1996-12-20 JP JP9527225A patent/JP2000504334A/en active Pending
-
1998
- 1998-07-28 NO NO983464A patent/NO983464D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2000504334A (en) | 2000-04-11 |
DE19648650C2 (en) | 1998-07-02 |
AU1870497A (en) | 1997-08-22 |
CA2244213A1 (en) | 1997-08-07 |
NO983464L (en) | 1998-07-28 |
DE19648650A1 (en) | 1997-08-07 |
WO1997028104A8 (en) | 1997-12-18 |
WO1997028104A3 (en) | 1997-09-12 |
EP0877628A2 (en) | 1998-11-18 |
WO1997028104A2 (en) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974618D0 (en) | Pharmaceutical preparations for intranasal administration | |
NO986023D0 (en) | Water-based pharmaceutical preparations | |
IS5953A (en) | Pharmaceutical preparations from microplated eplerenones | |
NO945054L (en) | Implementation Independent Interface Specification System | |
NO954146D0 (en) | Coated pharmaceutical preparations | |
DE69711045T2 (en) | VITAMIN C DELIVERY SYSTEM | |
BR9611367A (en) | Stable lyophilized pharmaceutical formulation | |
DE69625368T2 (en) | SWEAT-RESISTANT DEODORATING PREPARATIONS | |
DK0981375T3 (en) | Pharmaceutical preparations containing plasma protein | |
NO20016277D0 (en) | Systems and methods for aerolizing pharmaceutical formulations | |
DE59703144D1 (en) | ACTIVE SUSPENSION SYSTEM | |
DE59701787D1 (en) | MEDICINE DOSING SYSTEM | |
DK1124582T3 (en) | Preservation system for topically deliverable pharmaceutical preparations | |
FI961437A0 (en) | Active substance delivery system | |
NO983464D0 (en) | Buffer systems for stabilizing pharmaceutical preparations | |
NO982874D0 (en) | Pharmaceutical preparations with vitamin D analogues | |
DE69719151T2 (en) | processing system | |
DE59707298D1 (en) | DESODORING PREPARATIONS | |
EE9900260A (en) | Pharmaceutical compositions for freeze-drying | |
ID16781A (en) | PHARMACEUTICAL FORMULATIONS | |
DK0925273T3 (en) | Pharmaceutical preparations containing 4-oxo-butanoic acids | |
DK1041966T3 (en) | Pharmaceutical preparations comprising zafirlukast | |
DE69714166T2 (en) | amplifier system | |
EE03511B1 (en) | Prolonged release pharmaceutical preparations containing misolastin | |
NO951350D0 (en) | Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |